Use of blood donor screening data to estimate zika virus incidence, Puerto Rico, April–August 2016

Emerging Infectious Diseases

Volumn 23, Issue 5, 2017, Pages 790-795

  Chevalier, Michelle S ^a   Biggerstaff, Brad J ^a   Basavaraju, Sridhar V ^a   Bañez Ocfemia, M Cheryl ^a   Alsina, Jose O ^b   Climent Peris, Consuelo ^c   Moseley, Robin R ^a   Chung, Koo Whang ^a   Rivera García, Brenda ^d   Bello Pagán, Melissa ^d   Pate, Lisa L ^e   Galel, Susan A ^e   Williamson, Phillip ^f   Kuehnert, Matthew J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Banco de Sangre de Servicios Mutuos   (United States)

^c Banco de Sangre del Centro Medico   (United States)

^d Puerto Rico Department of Health   (United States)

^e ROCHE MOLECULAR SYSTEMS   (United States)

^f CREATIVE TESTING SOLUTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PUERTO RICO; RISK FACTOR; VIREMIA; VIRUS TRANSMISSION; ZIKA FEVER; ZIKA VIRUS; ADOLESCENT; HEALTH SURVEY; HISTORY; IMMUNOLOGY; SEASON; YOUNG ADULT; ZIKA VIRUS INFECTION;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PUERTO RICO; SEASONS; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85018652461     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2305.161873     Document Type: Article

References (24)

1. Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110:569–72. http://dx.doi.org/10.1590/0074-02760150192
2. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med. 2016;374:1981–7. http://dx.doi.org/10.1056/NEJMsr1604338
3. Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a casecontrol study. Lancet. 2016;387:1531–9. http://dx.doi.org/10.1016/S0140-6736(16)00562-6
4. Karimi O, Goorhuis A, Schinkel J, Codrington J, Vreden SG, Vermaat JS, et al. Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection. Lancet. 2016;387:939–40. http://dx.doi.org/10.1016/S0140-6736(16)00502-X
5. Sharp TM, Muñoz-Jordán J, Perez-Padilla J, Bello-Pagán MI, Rivera A, Pastula DM, et al. Zika virus infection associated with severe thrombocytopenia. Clin Infect Dis. 2016;63:1198–201.
6. Lanteri MC, Kleinman SH, Glynn SA, Musso D, Keith Hoots W, Custer BS, et al. Zika virus: a new threat to the safety of the blood supply with worldwide impact and implications. Transfusion. 2016;56:1907–14. http://dx.doi.org/10.1111/trf.13677
7. Petersen LR, Busch MP. Transfusion-transmitted arboviruses. Vox Sang. 2010;98:495–503. http://dx.doi.org/10.1111/j.1423-0410.2009.01286.x
8. Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill. 2014;19:20761. http://dx.doi.org/10.2807/1560-7917.ES2014.19.14.20761
9. Barjas-Castro ML, Angerami RN, Cunha MS, Suzuki A, Nogueira JS, Rocco IM, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion. 2016;56:1684–8. http://dx.doi.org/10.1111/trf.13681
10. Motta IJ, Spencer BR, Cordeiro da Silva SG, Arruda MB, Dobbin JA, Gonzaga YB, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med. 2016;375:1101–3. http://dx.doi.org/10.1056/NEJMc1607262
11. Thomas DL, Sharp TM, Torres J, Armstrong PA, Munoz-Jordan J, Ryff KR, et al. Local Transmission of Zika Virus—Puerto Rico, November 23, 2015–January 28, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:154–8. http://dx.doi.org/10.15585/mmwr.mm6506e2
12. Centers for Disease Control and Prevention. Zika virus: case counts in the US [cited 2016 Aug 12]. http://www.cdc.gov/zika/geo/united-states.html
13. Food and Drug Administration. Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus [cited 2016 Nov 15]. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf
14. Food and Drug Administration. FDA allows use of investigational test to screen blood donations for Zika virus [cited 2016 Nov 15]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm493081.htm
15. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006;12:395–402. http://dx.doi.org/10.3201/eid1205.051287
16. Vasquez AM, Sapiano MR, Basavaraju SV, Kuehnert MJ, Rivera-Garcia B. Survey of blood collection centers and implementation of guidance for prevention of transfusion-transmitted Zika virus infection—Puerto Rico, 2016. Am J Transplant. 2016;16:2487–90. http://dx.doi.org/10.1111/ajt.13941
17. Puerto Rico Department of Health. Zika reports by municipality [cited 2016 Aug 15]. http://www.salud.gov.pr/Estadisticas-Registros-y-Publicaciones/Informes%20Zika%20por%20Municipios/Forms/AllItems.aspx
18. US Census Bureau. American fact finder [cited 2016 Aug 30]. http://factfinder.census.gov/faces/nav/jsf/pages/index.xhtml
19. Lessler J, Ott CT, Carcelen AC, Konikoff JM, Williamson J, Bi Q, et al. Times to key events in Zika virus infection and implications for blood donation: a systematic review. Bull World Health Organ. 2016;94:841–9. http://dx.doi.org/10.2471/BLT.16.174540
20. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jääskeläinen AJ, Smura T, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med. 2016; 374:2142–51. http://dx.doi.org/10.1056/NEJMoa1601824
21. Puerto Rico Department of Health. Informe de Zika por Municipios [cited 2016 Nov 16]. https://www.salud.gov.pr/Estadisticas-Registros-y-Publicaciones/Informes%20Zika%20por%20Municipios/Informe_Municipios%20semana%2030-2016.pdf
22. Busch MP, Sabino EC, Brambilla D, Lopes ME, Capuani L, Chowdhury D, et al.; International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Duration of dengue viremia in blood donors and relationships between donor viremia, infection incidence and clinical case reports during a large epidemic. J Infect Dis. 2016;214:49–54. http://dx.doi.org/10.1093/infdis/jiw122
23. Simmons G, Brès V, Lu K, Liss NM, Brambilla DJ, Ryff KR, et al. High incidence of chikungunya virus and frequency of viremic blood donations during epidemic, Puerto Rico, USA, 2014. Emerg Infect Dis. 2016;22:1221–8. http://dx.doi.org/10.3201/eid2207.160116
24. Food and Drug Administration. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components [cited 2016 Nov 15]. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInforma-tion/Guidances/Blood/UCM518213.pdf